Cargando…
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406871/ https://www.ncbi.nlm.nih.gov/pubmed/37550302 http://dx.doi.org/10.1038/s41467-023-40561-x |
| _version_ | 1785085832668905472 |
|---|---|
| author | Coombes, R. C. Howell, Sacha Lord, Simon R. Kenny, Laura Mansi, Janine Mitri, Zahi Palmieri, Carlo Chap, Linnea I. Richards, Paul Gradishar, William Sardesai, Sagar Melear, Jason O’Shaughnessy, Joyce Ward, Patrick Chalasani, Pavani Arkenau, Tobias Baird, Richard D. Jeselsohn, Rinath Ali, Simak Clack, Glen Bahl, Ashwani McIntosh, Stuart Krebs, Matthew G. |
| author_facet | Coombes, R. C. Howell, Sacha Lord, Simon R. Kenny, Laura Mansi, Janine Mitri, Zahi Palmieri, Carlo Chap, Linnea I. Richards, Paul Gradishar, William Sardesai, Sagar Melear, Jason O’Shaughnessy, Joyce Ward, Patrick Chalasani, Pavani Arkenau, Tobias Baird, Richard D. Jeselsohn, Rinath Ali, Simak Clack, Glen Bahl, Ashwani McIntosh, Stuart Krebs, Matthew G. |
| author_sort | Coombes, R. C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10406871 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104068712023-08-09 Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib Coombes, R. C. Howell, Sacha Lord, Simon R. Kenny, Laura Mansi, Janine Mitri, Zahi Palmieri, Carlo Chap, Linnea I. Richards, Paul Gradishar, William Sardesai, Sagar Melear, Jason O’Shaughnessy, Joyce Ward, Patrick Chalasani, Pavani Arkenau, Tobias Baird, Richard D. Jeselsohn, Rinath Ali, Simak Clack, Glen Bahl, Ashwani McIntosh, Stuart Krebs, Matthew G. Nat Commun Author Correction Nature Publishing Group UK 2023-08-07 /pmc/articles/PMC10406871/ /pubmed/37550302 http://dx.doi.org/10.1038/s41467-023-40561-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Coombes, R. C. Howell, Sacha Lord, Simon R. Kenny, Laura Mansi, Janine Mitri, Zahi Palmieri, Carlo Chap, Linnea I. Richards, Paul Gradishar, William Sardesai, Sagar Melear, Jason O’Shaughnessy, Joyce Ward, Patrick Chalasani, Pavani Arkenau, Tobias Baird, Richard D. Jeselsohn, Rinath Ali, Simak Clack, Glen Bahl, Ashwani McIntosh, Stuart Krebs, Matthew G. Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib |
| title | Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib |
| title_full | Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib |
| title_fullStr | Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib |
| title_full_unstemmed | Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib |
| title_short | Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib |
| title_sort | author correction: dose escalation and expansion cohorts in patients with advanced breast cancer in a phase i study of the cdk7-inhibitor samuraciclib |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406871/ https://www.ncbi.nlm.nih.gov/pubmed/37550302 http://dx.doi.org/10.1038/s41467-023-40561-x |
| work_keys_str_mv | AT coombesrc authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT howellsacha authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT lordsimonr authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT kennylaura authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT mansijanine authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT mitrizahi authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT palmiericarlo authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT chaplinneai authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT richardspaul authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT gradisharwilliam authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT sardesaisagar authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT melearjason authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT oshaughnessyjoyce authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT wardpatrick authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT chalasanipavani authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT arkenautobias authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT bairdrichardd authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT jeselsohnrinath authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT alisimak authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT clackglen authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT bahlashwani authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT mcintoshstuart authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib AT krebsmatthewg authorcorrectiondoseescalationandexpansioncohortsinpatientswithadvancedbreastcancerinaphaseistudyofthecdk7inhibitorsamuraciclib |